The diagnostic usefulness of capture assays for measuring global/specific extracellular micro-particles in plasma

Transfusion and Apheresis Science

Volumn 53, Issue 2, 2015, Pages 127-136

  Amiral, Jean ^a   Seghatchian, Jerard ^b  

^a SYSMEX CORPORATION   (Japan)

^b Audit Inspection and DDR Strategy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBIN;

ARTICLE; CAPTURE ASSAY; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; IMMUNOASSAY; LEUKOCYTE MICROPARTICLE; MEMBRANE MICROPARTICLE; MONOCYTE; PLASMA CELL; PLATELET MICROPARTICLE; ANIMAL; BLOOD; BLOOD CELL; METABOLISM; NEOPLASM; PATHOLOGY; PROCEDURES;

ANIMALS; BLOOD CELLS; CELL-DERIVED MICROPARTICLES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XA; HUMANS; NEOPLASMS; PHOSPHATIDYLSERINES;

EID: 84951804019     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.10.009     Document Type: Article

References (77)

1. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 2003, 1:1655-1662.
2. Goubran H.A., Burnouf T., Stakiw J., Seghatchian J. Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease. Transfus Apher Sci 2015, 52:12-18.
3. Zwicker J.I., Lacroix R., Dignat-George F., Furie B.C., Furie B. Measurement of platelet microparticles. Platelets and megakaryocytes 2012, 127-139. Springer, 788.
4. Chironi G.N., Boulanger C.M., Simon A., Dignat-George F., Freyssinet J.-M., Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009, 335:143-151.
5. Enjeti A.K., Lincz L.F., Seldon M. Microparticles in health and disease. Semin Thromb Hemost 2008, 683-691.
6. Burnouf T., Goubran H.A., Chou M.L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28:155-166.
7. Ardoin S., Shanahan J., Pisetsky D. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007, 66:159-165.
8. Geddings J.E., Mackman N. New players in haemostasis and thrombosis. Thromb Haemost 2014, 111:570-574.
9. Lawrie A., Harrison P., Cardigan R., Mackie I. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008, 95:197-204.
10. Seghatchian J., Krailadsiri P. Current position on preparation and quality of leucodepleted platelet concentrates for clinical use. Transfus Sci 2000, 22:85-88.
11. Krailadsiri P., Seghatchian J., Bode A.P. State-of-the-art-review: microvesicles in blood components: laboratory and clinical aspects. Clinical and Applied Thrombosis/Hemostasis 1997, 3:86-95.
12. Cheng W.C., Lo S.C., Tsai K.S., Tu S.T., Wu J.S., Chang C.I., et al. Effects of high-dose phytoestrogens on circulating cellular microparticles and coagulation function in postmenopausal women. J Formos Med Assoc 2015, 114(8):710-716.
13. Lubsczyk B., Kollars M., Hron G., Kyrle P.A., Weltermann A., Gartner V. Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans. Eur J Clin Invest 2010, 40:477-482.
14. Bouchama A., Kunzelmann C., Dehbi M., Kwaasi A., Eldali A., Zobairi F., et al. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke. Arterioscler Thromb Vasc Biol 2008, 28:1318-1325.
15. Proulle V., Hugel B., Guillet B., Trichet C., Rafowicz A., Lambert T., et al. Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles. Thromb Haemost 2004, 91:873-878.
16. Morel O., Jesel L., Hugel B., Douchet M.P., Zupan M., Chauvin M., et al. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J Thromb Haemost 2003, 1:171-177.
17. Woei-A-Jin F.S.H., van der Starre W.E., Tesselaar M.E., Rodriguez P.G., van Nieuwkoop C., Bertina R.M., et al. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections. Thromb Res 2014, 133:799-803.
18. Baron M., Boulanger C.M., Staels B., Tailleux A. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?. J Cell Mol Med 2012, 16:1365-1376.
19. Owen B., Xue A., Heit J., Owen W. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism. Thromb Res 2011, 127:39-46.
20. Morel O., Pereira B., Averous G., Faure A., Jesel L., Germain P., et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009, 204:636-641.
21. Michelsen A.E., Brodin E., Brosstad F., Hansen J.-B. Increased level of platelet microparticles in survivors of myocardial infarction. Scand J Clin Lab Invest 2008, 68:386-392.
22. Ederhy S., Di Angelantonio E., Mallat Z., Hugel B., Janower S., Meuleman C., et al. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. Am J Cardiol 2007, 100:989-994.
23. Tantawy A.A., Adly A.A., Ismail E.A., Habeeb N.M. Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness. Eur J Haematol 2013, 90:508-518.
24. Woth G., Tokés-Füzesi M., Magyarlaki T., Kovács G.L., Vermes I., Mühl D. Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann Clin Biochem 2012, 49:554-560.
25. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012, 110:356-369.
26. Gunduz Z., Dursun I., Tulpar S., Bastug F., Baykan A., Yikilmaz A., et al. Increased endothelial microparticles in obese and overweight children. J Pediat Endocrinol Metabol 2012, 25:1111-1117.
27. van Beers E.J., Schaap M.C., Berckmans R.J., Nieuwland R., Sturk A., van Doormaal F.F., et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94:1513-1519.
28. Šimák J., Holada K., Vostal J.G. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol 2002, 3:11.
29. Bode M., Mackman N. Protective and pathological roles of tissue factor in the heart. Hamostaseologie 2014, 35:37-46.
30. González-Quintero V.H., Smarkusky L.P., Jiménez J.J., Mauro L.M., Jy W., Hortsman L.L., et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol 2004, 191:1418-1424.
31. Sahu U., Sahoo P.K., Kar S.K., Mohapatra B.N., Ranjit M. Association of TNF level with production of circulating cellular microparticles during clinical manifestation of human cerebral malaria. Hum Immunol 2013, 74:713-721.
32. Chamouard P., Desprez D., Hugel B., Kunzelmann C., Gidon-Jeangirard C., Lessard M., et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci 2005, 50:574-580.
33. Kasthuri R.S., Glover S.L., Jonas W., McEachron T., Pawlinski R., Arepally G.M., et al. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood 2012, 119:5285-5293.
34. Warkentin T.E., Hayward C., Boshkov L., Santos A., Sheppard J., Bode A., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994, 84:3691-3699.
35. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost 2014, 296-305.
36. Hernández C., Orbe J., Roncal C., Alvarez-Hernandez M., de Lizarrondo S.M., Alves M.T., et al. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients. Thromb Haemost 2013, 110:598-608.
37. Geddings J.E., Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 2013, 122:1873-1880.
38. Bharthuar A., Khorana A.A., Hutson A., Wang J.-G., Key N.S., Mackman N., et al. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res 2013, 132:180-184.
39. Thaler J., Ay C., Mackman N., Bertina R., Kaider A., Marosi C., et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 2012, 10:1363-1370.
40. Thaler J., Ay C., Weinstabl H., Dunkler D., Simanek R., Vormittag R., et al. Circulating procoagulant microparticles in cancer patients. Ann Hematol 2011, 90:447-453.
41. Auwerda J.J., Yuana Y., Osanto S., de Maat M.P., Sonneveld P., Bertina R.M., et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2011, 105:14-20.
42. Rodriguez P.G., Eikenboom H., Tesselaar M., Huisman M., Nijkeuter M., Osanto S., et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 2010, 126:345-349.
43. Davila M., Amirkhosravi A., Coll E., Desai H., Robles L., Colon J., et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008, 6:1517-1524.
44. Kanazawa S., Nomura S., Kuwana M., Muramatsu M., Yamaguchi K., Fukuhara S. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 2003, 39:145-149.
45. Goubran H.A., Sabry W., Kotb R., Seghatchian J., Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015, 53(2):168-172.
46. Jayachandran M., Litwiller R.D., Lahr B.D., Bailey K.R., Owen W.G., Mulvagh S.L., et al. Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res 2011, 4:811-822.
47. Li M., Yu D., Williams K.J., Liu M.-L. Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arterioscler Thromb Vasc Biol 2010, 30:1818-1824.
48. Agouni A., Lagrue-Lak-Hal A.H., Ducluzeau P.H., Mostefai H.A., Draunet-Busson C., Leftheriotis G., et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008, 173:1210-1219.
49. Goichot B., Grunebaum L., Desprez D., Vinzio S., Meyer L., Schlienger J., et al. Circulating procoagulant microparticles in obesity. Diabetes Metab 2006, 32:82-85.
50. Shet A.S., Aras O., Gupta K., Hass M.J., Rausch D.J., Saba N., et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003, 102:2678-2683.
51. Burnouf T., Goubran H.A., Chou M.-L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28(4):155-166.
52. van der Pol E., Coumans F.A., Sturk A., Nieuwland R., van Leeuwen T.G. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett 2014, 14:6195-6201.
53. van der Pol E., Coumans F., Varga Z., Krumrey M., Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost 2013, 11(Suppl. 1):36-45.
54. van der Pol E., Hoekstra A.G., Sturk A., Otto C., van Leeuwen T.G., Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010, 8:2596-2607.
55. Van der Pol E., Coumans F., Grootemaat A., Gardiner C., Sargent I., Harrison P., et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost 2014, 12:1182-1192.
56. Iversen L.V., Østergaard O., Nielsen C.T., Jacobsen S., Heegaard N.H. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer. J Immunol Methods 2013, 388:49-59.
57. Robert S., Lacroix R., Poncelet P., Harhouri K., Bouriche T., Judicone C., et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles - brief report. Arterioscler Thromb Vasc Biol 2012, 32:1054-1058.
58. Ayers L., Kohler M., Harrison P., Sargent I., Dragovic R., Schaap M., et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011, 127:370-377.
59. Mobarrez F., Antovic J., Egberg N., Hansson M., Jörneskog G., Hultenby K., et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010, 125:e110-6.
60. Kim H., Song K., Lee E., Lee Y., Park Y., Lee K., et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinol 2002, 13:393-397.
61. Shirafuji T., Hamaguchi H., Higuchi M., Kanda F. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients. Muscle Nerve 2009, 39:586-590.
62. Shirafuji T., Hamaguchi H., Kanda F. Measurement of platelet-derived microparticle levels in the chronic phase of cerebral infarction using an enzyme-linked immunosorbent assay. Kobe J Med Sci 2008, 54:E55-61.
63. Miyamoto S., Marcinkiewicz C., Edmunds L.H., Niewiarowski S. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa. Thromb Haemost 1998, 80:225-230.
64. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J.-L., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997, 99:1546.
65. Key N.S. Analysis of tissue factor positive microparticles. Thromb Res 2010, 125:S42-5.
66. Key N.S., Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost 2010, 865-875.
67. Tilley R.E., Holscher T., Belani R., Nieva J., Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 2008, 122:604-609.
68. Yuana Y., Bertina R.M., Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011, 105:396-408.
69. Poncelet P., Robert S., Bailly N., Garnache-Ottou F., Bouriche T., Devallet B., et al. Tips and tricks for flow cytometry-based analysis and counting of microparticles. Transf Apher Sci 2015, 53(2):110-126.
70. Versteeg H.H., Schaffner F., Kerver M., Petersen H.H., Ahamed J., Felding-Habermann B., et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008, 111:190-199.
71. Bernimoulin M., Waters E.K., Foy M., Steele B.M., Sullivan M., Falet H., et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost 2009, 7:1019-1028.
72. Collier M.E., Mah P.-M., Xiao Y., Maraveyas A., Ettelaie C. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity. Thromb Haemost 2013, 110:966-976.
73. Lacroix R., Judicone C., Poncelet P., Robert S., Arnaud L., Sampol J., et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. Int J Lab Hematol 2012, 34:159-160.
74. Lee R., Barcel D., Williams J., Wang J., Boles J., Manly D., et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 2012, 129:80-85.
75. Michelson A.D., Barnard M.R., Hechtman H.B., MacGregor H., Connolly R.J., Loscalzo J., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996, 93:11877-11882.
76. Aleman M.M., Gardiner C., Harrison P., Wolberg A.S. Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost 2011, 9:2251-2261.
77. Connor D.E., Exner T., Ma D.D., Joseph J.E. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinol 2009, 20:558-564.